Minerva Surgical, Inc. (UTRS): Price and Financial Metrics
GET POWR RATINGS... FREE!
UTRS Stock Price Chart Interactive Chart >
UTRS Price/Volume Stats
| Current price | $2.35 | 52-week high | $10.37 |
| Prev. close | $2.23 | 52-week low | $1.61 |
| Day low | $2.23 | Volume | 11,700 |
| Day high | $2.38 | Avg. volume | 42,663 |
| 50-day MA | $3.91 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 67.76M |
Minerva Surgical, Inc. (UTRS) Company Bio
Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Latest UTRS News From Around the Web
Below are the latest news stories about Minerva Surgical Inc that investors may wish to consider to help them evaluate UTRS as an investment opportunity.
Minerva Surgical to Announce Fourth Quarter and Full-Year Financial ResultsSANTA CLARA, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its fourth quarter and full-year 2021 financial results on Tuesday, March 8, 2022. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. |
Minerva Surgical to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceSANTA CLARA, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022 at 3:40 p.m. Eastern Time. A live audio webcast and replay of the presentation may be accessed through the “Recent Events” section of Minerva’s website at http://ir.minervasurgica |
Minerva Surgical, Inc.'s (NASDAQ:UTRS) recent US$21m market cap decline means a loss of US$3.3k for insiders who bought this yearThe recent price decline of 13% in Minerva Surgical, Inc.'s ( NASDAQ:UTRS ) stock may have disappointed insiders who... |
Minerva Surgical's Preliminary FY21 Revenues Top ExpectationsView more earnings on UTRSSee more from BenzingaB. Riley Beefs Up Intercept Target Price On Catalyst Rich 1H 2022Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. |
Minerva Surgical Reports Preliminary Fourth Quarter and Full Year 2021 RevenueSANTA CLARA, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a medical device company that has established a broad product line of commercially available, minimally invasive medical devices that address the most common causes of abnormal uterine bleeding (AUB) as alternatives to hysterectomy, today reported preliminary unaudited fourth quarter and full year 2021 revenue expectations. Preliminary Fourth Quarter and Full Year 2021 |
UTRS Price Returns
| 1-mo | -44.71% |
| 3-mo | -55.24% |
| 6-mo | -71.52% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -54.28% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...